1. Home
  2. BELFA vs BCRX Comparison

BELFA vs BCRX Comparison

Compare BELFA & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bel Fuse Inc.

BELFA

Bel Fuse Inc.

HOLD

Current Price

$193.19

Market Cap

2.3B

Sector

N/A

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$9.50

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BELFA
BCRX
Founded
1949
1986
Country
United States
United States
Employees
4964
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
BELFA
BCRX
Price
$193.19
$9.50
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$20.82
AVG Volume (30 Days)
53.7K
6.3M
Earning Date
04-23-2026
05-04-2026
Dividend Yield
0.12%
N/A
EPS Growth
N/A
381.40
EPS
N/A
1.21
Revenue
N/A
$25,186,000.00
Revenue This Year
$28.52
N/A
Revenue Next Year
$7.85
$12.55
P/E Ratio
$40.02
$7.76
Revenue Growth
N/A
N/A
52 Week Low
$53.95
$6.00
52 Week High
$227.42
$11.31

Technical Indicators

Market Signals
Indicator
BELFA
BCRX
Relative Strength Index (RSI) 49.54 65.87
Support Level $114.22 $7.85
Resistance Level $227.42 N/A
Average True Range (ATR) 8.94 0.57
MACD 1.53 0.02
Stochastic Oscillator 62.13 63.13

Price Performance

Historical Comparison
BELFA
BCRX

About BELFA Bel Fuse Inc.

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: